Associate Professor
University of Nevada, Las Vegas, Nevada, United States
Dr. Kleiger began his career as a structural biologist in the laboratory of Dr. David Eisenberg (UCLA). Dr. Kleiger then joined the laboratory of Dr. Ray Deshaies (formerly Caltech and now Vice President of global research, Amgen) focusing on the ubiquitin system and the application of biochemical and enzymological techniques to uncover enzyme mechanism. Dr. Kleiger is an expert in targeted protein degradation and a leader in the application of enzyme kinetics to the ubiquitylation reaction. Dr. Kleiger's research is at the nexus of understanding how ubiquitylating enzymes function at the molecular level and how to harness the power of these enzymes to treat various human diseases such as cancer. He is involved in both academic and industry collaborations seeking insights into the targeted degradation of disease-causing proteins.
Disclosure information not submitted.
Monday, February 7, 2022
10:00 AM – 10:30 AM